US Patent Issued to BioLegend on Oct. 14 for "Anti-TLR9 agents and compositions and methods for making and using the same" (American, Japanese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,806, issued on Oct. 14, was assigned to BioLegend Inc. (San Diego).

"Anti-TLR9 agents and compositions and methods for making and using the same" was invented by Nicole Vivienne Acuff (San Diego), Anagha Ashok Divekar (San Diego) and Takatoku Oida (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for making and using anti-TLR9 agents, for example, monoclonal antibodies, TLR9-binding antibody fragments, and derivatives are described, as are kits, nucleic acids encoding such molecules, diagnostic reagents and kits that include anti-TLR9 agents, and methods of making and using the same."

The patent was filed on Marc...